HomeUSACancerX Launches Inaugural Startup Accelerator Cohort

CancerX Launches Inaugural Startup Accelerator Cohort


CancerX, a public-private partnership to boost innovation in the fight against cancer co-hosted by the Digital Medicine Society (DiMe) and Moffitt Cancer Center, announced the 16 startup members of its inaugural Accelerator cohort.

Announced by The White House Cancer Moonshot in February 2023, CancerX has selected The Blue Box, C the Signs, Cancer Insights, Curvia, EnteroTrack, Gesund.ai, Gray Oncology, LindAI, Mika Health, Navya, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, and Xanthos. 

The cohort will now participate in a 4-month program during which they will work with Accelerator Champions and engage with Mentors and CancerX members from across the healthcare ecosystem, including investors, provider organizations, and oncology experts, to test and validate their solutions.

Startups will graduate from the Accelerator with a roadmap to scale their company, an opportunity to move forward with their sponsor, and a community that will continue to support their solution development.

CancerX will build on the success of the inaugural round and plans to open Accelerator applications for a second cohort in the fall of this year.

The partnership has already launched two projects:

  • a data sprint to support the collective efforts of the Center for Medicare and Medicaid Innovation (CMMI), the National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and ONC to advance cancer-related data standards; and
  • open sources resources to guide in the advancement of digital innovation to improve equity and reduce financial toxicity in cancer care and research.